Cinobufacini (huachansu) is a traditional Chinese medicine extracted from the skin of Bufo bufo gargarizans, which is used in clinical cancer therapy. The purpose of this study was to investigate the signaling pathways regulating cinobufacini-induced apoptosis in the osteosarcoma cell line, U 2 OS. We used 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) assay to evaluate the effects of cinobufacini on cell proliferation in U 2 OS cells. Changes in cell morphology and apoptosis were detected by TUNEL staining. The expression of apoptosis-related and Wnt/β-catenin pathway proteins was detected by immunofluorescence, RT-PCR, and western blot analysis. Our data indicated that cinobufacini significantly inhibited cell proliferation in a dose-and timedependent manner. Marked changes in cell morphology and apoptosis rate were clearly observed after cinobufacini treatment. The Wnt/β-catenin pathway was activated, and β-catenin expression was positive in cells after treatment. Further, protein expression of bax was increased, whereas bcl-2 was decreased, resulting in an increased bax/bcl-2 ratio. Moreover, after cinobufacini treatment, the expression of Wnt/β-catenin pathway-related proteins was similar to controls. Taken together, our study indicates that cinobufacini can induce apoptosis in U 2 OS cells, likely through activating the Wnt/β-catenin pathway.
Osteosarcoma is the most common primary bone malignancy, and has the eighth highest incidence among childhood cancers [1] . In addition to surgery, neo-adjuvant chemotherapy is also applied to treat osteosarcoma. Although these therapies induce tumor cell death, they also damage normal cells. Further, maintaining highdose chemotherapy in adults with osteosarcoma does not affect survival, histological response, recurrence, and time to recurrence [2] . Clinical trials have confirmed that combining cinobufacini injection with chemotherapy may enhance the effect of conventional therapies [3, 4] . The use of cinobufacini injection in cancer patients might improve their quality of life. Importantly, cinobufacini has no dose-limiting toxicities and has a less potent cytotoxic effect in normal cells [5] .
Cinobufacini (huachansu), an extract used in traditional Chinese medicine, is obtained from the skin and parotid venom glands of Bufo bufo gargarizans Cantor [6, 7] . A previous study reported that cinobufacini has immunomodulatory and antineoplastic effects [8] .
Further, a number of recent studies provided evidence suggesting that cinobufacini has anti-tumor effects [9] [10] [11] [12] [13] . Especially, Luo SL et al found that a new C23 steroid from the venom of Bufo bufo gargarizans could against human hepatocarcinoma HepG2 cells [14] . In particular, a study showed that cinobufacini, when combined with doxorubicin, has profound benefits in hepatocellular carcinoma cells, and induced more significant apoptosis by affecting proteins and RNA of apoptosis-related elements [15] . Furthermore, a long-term follow-up study showed that patients treated with cinobufacini and Jiedu granules had a lower rate of small-sized hepatocellular carcinoma recurrence than those treated with transarterial chemoembolization after resection [16] .
Cinobufacini contains many components, including bufadienolides, steroids, indole alkaloids, peptides, and organic acids [17] . Bufadienolides, bufalin, and cinobufagin are the major bioactive components of cinobufacini [18] . Bufalin was shown to have antitumor activity in osteosarcoma cells through the regulation of mitochondria-dependent signaling pathways [19] . Further, a study showed that cinobufagin can induce apoptosis in U 2 OS cells via the glycogen synthase kinase (GSK)-3β/nuclear factor (NF)-κB pathway [20] . A previous study also showed that combination therapy using cinobufacini and cisplatin enhanced OS-732 cell death through the upregulation of Fas [4] . However, the anti-tumor effects of cinobufacini in osteosarcoma cells, and the pathways regulated by cinobufacini in these cells, remain unknown. Wnt signaling pathway plays an important role in tumor biology research, and is generally believed that activation of Wnt pathway is the cause of tumorigenesis. Wnt/β-catenin signaling pathway is concerned much as a canonical Wnt signaling pathway in cancer research. β-Catenin is a positive regulator of Wnt signaling pathway, its degradation in cytoplasm and accumulation in nucleus can activate transcription of target genes and lead to a series of tumorigenesis. While the activity of Wnt signaling pathway in osteosarcoma remains unclear. It is well known that the Wnt/β-catenin pathway regulates bone and cartilage metabolism by stimulating the replication of stem cells, inducing osteoblasts, and depressing the apoptosis of bone cell. A previous study showed that loss of Wnt/β-catenin pathway activity, which is required for osteoblast differentiation, may contribute to osteosarcoma development [21] . However, a different study showed that Wnt/β-catenin pathway activity was correlated with osteosarcoma [22] . This study initially explored whether cinobufacini induces apoptosis NPC Natural Product Communications 2018 Vol. 13 
No. 2 201 -204
in osteosarcoma cells through the Wnt/β-catenin pathway. Research on Wnt signaling pathway is hot in cancer. Generally considered that activation of Wnt pathway is directly correlated with tumorigenesis. In malignancies, mainly studies are explored on the key proteins or receptors in wnt pathway. The purpose of this study was to confirm the ability of cinobufacini to inhibit osteosarcoma cell growth, and to determine its effects on the Wnt/β-catenin pathway in osteosarcoma cells.
GSK-3β kinase activity and β-catenin stability affect Wnt/β-catenin signaling directly. Inhibition of GSK-3β/NF-κB signaling could induce apoptosis in OS cells [20] . The Endothelial Transcription Factor ERG could control Wnt/β-catenin pathway through promoting β-catenin stability, and the stabilization of β-catenin levels activated Wnt/β-catenin pathway [23] . Our data indicates that the expression of Wnt/β-catenin pathway proteins changed in a time-dependent manner. This may be due to inhibition of β-catenin degradation after inactivation of GSK-3β reducing β-catenin phosphorylation when cinobufacini treatment on osteosarcoma cells, thus the stability and expression of β-catenin in the cells was increased, and the wnt signaling pathway was activated. Our research demonstrated a relationship between cinobufacini and osteosarcoma cell apoptosis. However, the specific mechanism must be further confirmed.
The MTT assay was used to evaluate the anti-proliferative effect of cinobufacini in osteosarcoma cells. As shown in Figure. Apoptosis was evaluated using TUNEL staining. The osteosarcoma cells were stained with DAPI and TUNEL following 24, or 48 h cinobufacini (1.5 μg/mL) treatment. Blue staining represents the nucleus and green staining represents apoptotic cells, as shown in Figure. Figure. 2 (A) . The Apoptosis rate changes after cells treated by cinobufacini when using TUNEL method for 24, 48 h in Figure. 2 (B) , we can see that as extension of time for cinobufacini treatment, the proportion of apoptotic cells increased gradually (F=113.461, P<0.01).
Immunofluorescence was used to determine the localization of apoptosis-related and Wnt/β-catenin pathway proteins in osteosarcoma cells. Following treatment with cinobufacini (1.5 μg/mL) for 24, or 48 h, both pro-apoptotic proteins (bax and Caspase-3) and anti-apoptotic proteins (bcl-2) were expressed in the cytosol. While, GSK-3β and axin 2 were expressed in the cytoplasm, β-catenin was expressed in the nucleus, as showed in Figure. 3 (A). As a result, the level of pro-apoptotic proteins increased, whereas anti-apoptotic proteins decreased. We can see the immuno-fluorescence intensity change in Figure. 3 
(B).
A B Figure. 3: After cells were treated with 1.5 μg/mL cinobufacini for 24, 48 h, the expression of pro-apoptotic proteins (bax and caspase-3) were increased, whereas antiapoptotic proteins (bcl-2) were reduced in a time-dependent manner. The expression of Wnt/β-catenin pathway proteins was obvious, as shown in the pictures. GSK-3β and axin 2 were expressed in the cytoplasm, β-catenin was expressed in the nucleus in Figure. 3 (A). The immunofluorescence intensity change of apoptosis-related and Wnt/β-catenin pathway proteins after cinobufacini treatment (F=127.293, P<0.05) in Figure. 3 (B). ), using 24 h as the control group. bax, axin2, and β-catenin were increased in a time-dependent manner, whereas bcl-2 and GSK-3β were reduced (F=115.548, P<0.05) in Figure. 4 (A) . The level of bax/bcl-2 ratio change was 4.57±0.32 and 9.25±0.55 after cinobufacini treatment by RT-PCR (F=98.658, P<0.05) in Figure. 4 
The mRNA expression of key pro-and anti-apoptotic and Wnt/β-catenin pathway genes was evaluated in osteosarcoma cells after treatment with cinobufacini in Figure. 4 (A) . The measured mRNAs were detected with RT-PCR, and normalized to control cells.
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Compared to the control group, bax, caspase-3, axin 2, and β/catenin were increased in a time-dependent manner, whereas bcl-2 and GSK-3β were reduced. Meaning while, we calculated the rate of bax/bcl-2 at different time, as showed in Figure. 4 
(B).
Western blot analysis was used to determine the proteins involved in cinobufacini-induced apoptosis in osteosarcoma cells. We evaluated bax, bcl-2, caspase-3, and the Wnt/β-catenin pathways proteins β-catenin, GSK-3β, and axin 2. Cinobufacini treatment upregulated bax and caspase-3, and downregulated bcl-2 in Figure. 5 (A). Further, β/catenin and axin 2 were upregulated, whereas GSK-3β was downregulated. The rate of bax/bcl-2 was also calculated, and the results were showed in Figure. 5 (B) . , and the TUNEL kit were purchased from the Beyotime Institute of Biotechnology (Nantong, Jiang Su, China). TRIzol reagent was purchased from Invitrogen Life Technologies (Grand Island, NY, USA), the RevertAid First Strand cDNA Synthesis kit was purchased from Thermo Fisher Scientific (Waltham, MA, USA), and 2X SYBR-Green PCR master mix was purchased from Ambion (Grand Island, NY, USA).
Cinobufacini: Cinobufacini was extracted from the skin of B. gargarizans Cantor. Briefly, the toad skin was boiled with distilled water twice, and the decoction was filtered and extracted with ethanol [24] [25] . In this study, cinobufacini was administered by injection (Anhui Jinchan Biochemical Co., Ltd., Anhui, China).
Cells and culture conditions: U 2 OS cells were obtained from Shanghai Institute of Biological Products Co., Ltd. (Shanghai, China). The cells were cultured in DMEM supplemented with 10% FBS, 100 U/mL penicillin, and 100 μg/mL streptomycin at 37C in a humidified atmosphere with 5% CO 2 . Cells in the logarithmic growth phase were used for experiments.
MTT assay: The MTT analysis was used to evaluate cell viability. Cells were harvested in the logarithmic growth phase at a density of 6×10 4 cells/ml, and were seeded in a 96-well plate. Cells were incubated for 24 h, followed by the addition of various concentrations of cinobufacini (0, 0.5, 1.0, 1.5, or 2.0 μg/mL). The MTT reagent was added at 24 and 48 h, following the manufacturer's instructions. The IC 50 values were calculated as described previously. TUNEL staining assay: TUNEL staining was used to observe apoptotic cell morphology. Cells (3×10 5 cells/ml) were seeded in 6-well plates and incubated for 24 h. Cinobufacini (1.5 μg/mL) was added to the cells for 24, 48 h. The cells were fixed with 4% formaldehyde in PBS for 30 min, and then incubated with 0.1% Triton X-100 for 20 min at room temperature. The cells were incubated with the TUNEL mixture for 2 h, and were stained with DAPI for 10 min. Finally, the TUNEL positive (green stained) cells were observed under a fluorescence microscope (Nikon Eclipse Ti-SR) and photographed at a magnification of 200 × after washing the cells in PBS.
Immunofluorescence assay: Paraffin-embedded samples were dewaxed and treated with an EDTA antigen retrieval buffer (pH 8.0/pH 9.0) with citrate (pH 6.0) for antigen retrieval. Cells were then rinsed with PBS three times and incubated with mouse-derived monoclonal primary antibodies purchased from Beyotime Institute of Biotechnology (Nantong, Jiang Su, China). Slides were then washed with PBS, and cells were incubated with secondary antibodies for 50 min. Finally, the cells were stained with DAPI for 10 min, and were observed under a fluorescence microscope (Nikon Eclipse Ti-SR).
RT-PCR assay:
Briefly, TRIzol reagent was added to the cells to extract the total RNA. Total RNA was then detected by UV spectrophotometer. cDNA was synthesized using the RevertAid First Strand cDNA Synthesis Kit. cDNA (5 µL; 1:100 dilution in water) was added to 12.5 µL of the 2×SYBR-Green PCR master mix (Ambion) with 800 nM of each primer, for a total volume of 25 µL. All reactions were run in triplicate, and included controls with no template or no reverse transcription. The oligonucleotide sequences of forward primers and reverse primers for these genes are designed by Primer Premier 5.0 software. In order to ensure accurate results, Actin was used as an internal control. The CT value of the measured mRNAs was defined after observing the extended curve, and then averaging the CT values following three replicates. The average CT value was compared with the internal control (△CT = CT measured protein -CT actin ). The △△CT was also evaluated (△△CT = △CT experimental group -△CT the control group ). Finally, the multiple of amplification of the measured protein (2 -△△ CT ) was used to determine its expression.
Western blot analysis assay: Cells were seeded in culture dishes and incubated for 24 h. The cells were treated with 1.5 μg/mL cinobufacini for 24, or 48 h, and then harvested and lysed in RIPA lysis buffer (20 mM Tris-HCl, pH 7.5, 1 mM EDTA, 1 mM DTT, 1 mM PMSF, and 1 mM protease inhibitor cocktail) for 30 min on ice. The lysates were centrifuged at 10,000 g for 10 min, and the supernatants were collected. Proteins (30 μg) were separated by SDS-PAGE and transferred onto polyvinylidene difluoride membranes. The membranes were first incubated in blocking solution (5% skim milk) for 1 h, and then incubated with mousederived monoclonal primary antibodies, purchased from Beyotime Institute of Biotechnology (Nantong, Jiang Su, China) for 12 h at 4C. Membranes were washed three times in Tris-buffered saline with Tween-20 (TBST) for 5 min. Finally, the membranes were incubated with HRP-labeled secondary antibodies for an additional hour, and were washed with TBST three times. The protein bands were visualized using an enhanced chemiluminescence detection system.
Statistical analysis:
All experimental data are presented as the mean ± standard deviation (SD). The statistical analysis was performed by ANOVA using SPSS 11.5 software.
